Promoter Vineet Sukumar invested Rs 200 crore to raise his stake to 11.5% in Vivriti Next. The move precedes an IPO before 2029, expanding products for mid-market clients, while private equity and global investors maintain majority stakes.
Standard Chartered India profit before tax grew 15% to $542 million in 2025, aided by lower expenses and provisions, despite a 3% drop in operating income. India rose to fourth in global profit contribution as China declined.
The U.S. Securities and Exchange Commission will give targets of investigations more time to respond to its notices of potential charges as part of a broader update of its internal enforcement protocols, the agency said.
Schaeffler India announced a Rs 35 per share dividend following a 36% YoY Q4 net profit rise to Rs 322 crore. Revenue grew 28% YoY, with sequential profit up 11%, reflecting robust operational performance.
The U.S. Federal Reserve could resume cutting interest rates if inflation starts to fall, but it would be risky to use expected productivity growth as a reason to loosen monetary policy now, Chicago Fed president Austan Goolsbee said as he waded into what is emerging as a core debate at the U.S. central bank.
Advanced Micro Devices said on Tuesday it has agreed to sell up to $60 billion worth of artificial intelligence chips to Meta Platforms over five years in a deal that allows the Facebook owner to purchase as much as 10% of the chip firm.
The Indian rupee closed modestly weaker on Tuesday, weighed down by a drop in local stocks and strong dollar demand from the non-deliverable forwards market, though losses were limited by central bank intervention.
HSBC argues that AI will not replace enterprise software but become embedded within it, acting as a supporting layer. The brokerage sees legacy software vendors as key beneficiaries of AI adoption, driven by agent-based integration, strong demand, and scalable enterprise deployment, even as tech stocks face near-term disruption concerns.
Eternal shares fell 6% amid heavy selling pressure, emerging as one of the top drags on the Sensex. Despite strong Q3 earnings and robust Blinkit growth, the stock has underperformed in 2026, trading below key moving averages as investor sentiment weakens on Dalal Street.
Shares of Natco Pharma and Eris Lifesciences climbed on Tuesday after announcing a partnership to commercialise Semaglutide in India. Natco rose over 6% to its highest level since January 8, while Eris gained nearly 4%, marking its third straight session of gains.
Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.